References
- Wherry EJ. T cell exhaustion. Nat Immunol 2011; 12:492–9; PMID:21739672; http://dx.doi.org/10.1038/ni.2035
- Verdeil G, Fuertes Marraco SA, Murray T, Speiser DE. From T cell “exhaustion” to anti-cancer immunity. Biochim Biophys Acta 2015; PMID:26123831; http://dx.doi.org/10.1016/j.bbcan.2015.06.007
- Giordano M, Henin C, Maurizio J, Imbratta C, Bourdely P, Buferne M, Baitsch L, Vanhille L, Sieweke MH, Speiser DE et al. Molecular profiling of CD8 T cells in autochthonous melanoma identifies maf as driver of exhaustion. EMBO J 2015; 34(15):2042–58; PMID:26139534; http://dx.doi.org/10.15252/embj.201490786
- Soudja SM, Wehbe M, Mas A, Chasson L, de Tenbossche CP, Huijbers I, Van den Eynde B, Schmitt-Verhulst AM. Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice. Cancer Res 2010; 70:3515–25; PMID:20406967; http://dx.doi.org/10.1158/0008-5472.CAN-09-4354
- Ho IC, Lo D, Glimcher LH. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med 1998; 188:1859–66; PMID:9815263; http://dx.doi.org/10.1084/jem.188.10.1859
- Rutz S, Noubade R, Eidenschenk C, Ota N, Zeng W, Zheng Y, Hackney J, Ding J, Singh H, Ouyang W. Transcription factor c-Maf mediates the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells. Nat Immunol 2011; 12:1238–45; PMID:22001828; http://dx.doi.org/10.1038/ni.2134
- Xu J. Yang Y, Qiu G, Lal G, Wu Z, Levy DE, Ochando JC, Bromberg JS, Ding Y. c-Maf regulates IL-10 expression during Th17 polarization. J Immunol 2009; 182:6226–36; PMID:19414776; http://dx.doi.org/10.4049/jimmunol.0900123
- Kroenke MA, Eto D, Locci M, Cho M, Davidson T, Haddad EK, Crotty S. Bcl6 and maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 2012; 188:3734–44; PMID:22427637; http://dx.doi.org/10.4049/jimmunol.1103246